Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.

Akram SaadJeffrey GoldsteinOfer MargalitEinat Shacham-ShmueliYaacov R LawrenceYu-Xiao YangKim A ReissTalia GolanRonac MamtaniNaama HalpernDan AderkaMeir MouallemAdam GoldsteinBruce GiantonioBen Boursi

Published in: Pharmacoepidemiology and drug safety (2020)

Beta-blocker use was not associated with increased pancreatic cancer risk. However, long-term use of beta-blockers may be associated with decreased pancreatic cancer risk.

Keyphrases

angiotensin converting enzyme
angiotensin ii
case control